新西兰扩大了获得关键药物的机会,使数千名患血癌和其他疾病的人受益。 New Zealand expands access to key medications, benefiting thousands with blood cancers and other conditions.

新西兰药房扩大了获得治疗血癌、炎症肠道疾病、风疹和关节炎的药物的机会,使数千名病人受益。 New Zealand's Pharmac has expanded access to medicines treating blood cancers, inflammatory bowel disease, eczema, and arthritis, benefiting thousands of patients. 这一决定是在政府投资6.04亿美元以及临床医生和病人群体的反馈之后作出的。 This decision follows a $604 million government investment and feedback from clinicians and patient groups. 这些变化于5月1日生效,每年还将节省4 000小时的注入时间,改善整个卫生系统。 The changes, taking effect May 1, will also save 4,000 hours of infusion time annually, improving the overall health system.